How do GLP-1s work to cause weight loss
Summary: Retatrutide commonly makes people feel reduced appetite and fullness after small meals, alongside gastrointestinal effects such as nausea, diarrhoea, and bloating, particularly during dose escalation
Wegovy is an injectable medication containing semaglutide, a GLP-1 receptor agonist
An agonist is a natural ligand or a substance mimics the action of natural ligands that initiates responses when it binds to a specific receptor
Contact us today for more information about Semaglutide GLP-1 injections or to book an appointment were happy to get started as soon as you are
Dina Peralta-Reich, M.D., a board-certified obesity medicine and pediatrics physician and the founder and director of New York Weight Wellness Medicine, a clinical practice that helps patients address eating disorders, weight maintenance, and issues related to overweight and obesity